Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1977 May;59(5):802–809. doi: 10.1172/JCI108702

Influence of a deficiency of the second component of complement on the bactericidal activity of neutrophils in vitro.

J E Repine, C C Clawson, P S Friend
PMCID: PMC372288  PMID: 323290

Abstract

Serum from three patients with a complete, selective deficiency of the second component of complement (C2) did not promote optimal killing of Staphylococcus aureus, 502A by neutrophilic polymorphonuclear leukocytes (PMN) in vitro. The addition of C2 reagent or the presence of heat-stable opsonin in the C2-deficient serum corrected the defective killing of S. aureus that was observed with patient or control PMN. PMN from the patients or control subjects killed bacteria with equal efficiency under conditions of optimal opsonization (normal pooled serum). However, twice-washed control PMN were better than patient PMN in killing S. aureus under circumstances of suboptimal opsonization (C2-deficient serum, heated C2-deficient serum, heated normal pooled serum, or no replacement of serum). The latter finding was due to residual C2 on the surface of twice-washed control cells. As repeated washing of control PMN progressively removed cell-associated C2, the staphylocidal effectiveness of the control RMN decreased to the level of patient PMN. In contrast to the findings with S. aureus, triply-washed PMN from patients or controls killed normal numbers of Escherichia coli, ON2, in C2-deficient serum.

Full text

PDF
802

Images in this article

803Image
on p.803

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agnello V., De Bracco M. M., Kunkel H. G. Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus. J Immunol. 1972 Mar;108(3):837–840. [PubMed] [Google Scholar]
  2. COHN Z. A., MORSE S. I. Interactions between rabbit polymorphonuclear leucocytes and staphylococci. J Exp Med. 1959 Sep 1;110:419–443. doi: 10.1084/jem.110.3.419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clawson C. C., Repine J. E. Quantitation of maximal bactericidal capability in human neutrophils. J Lab Clin Med. 1976 Aug;88(2):316–327. [PubMed] [Google Scholar]
  4. Day N. K., Geiger H., McLean R., Michael A., Good R. A. C2 deficiency. Development of lupus erythematosus. J Clin Invest. 1973 Jul;52(7):1601–1607. doi: 10.1172/JCI107337. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Friend P., Repine J. E., Clawson C. C., Michael A. F. Deficiency of the second component of complement (C2) with chronic vasculitis. Ann Intern Med. 1975 Dec;83(6):813–816. doi: 10.7326/0003-4819-83-6-813. [DOI] [PubMed] [Google Scholar]
  6. Gigli I., Nelson R. A., Jr Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3. Exp Cell Res. 1968 Jul;51(1):45–67. doi: 10.1016/0014-4827(68)90158-4. [DOI] [PubMed] [Google Scholar]
  7. Glass D., Raum D., Gibson D., Stillman J. S., Schur P. H. Inherited deficiency of the second component of complement. Rheumatic disease associations. J Clin Invest. 1976 Oct;58(4):853–861. doi: 10.1172/JCI108538. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HIRSCH J. G., CHURCH A. B. Studies of phagocytosis of group A streptococci by polymorphonuclear leucocytes in vitro. J Exp Med. 1960 Mar 1;111:309–322. doi: 10.1084/jem.111.3.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HIRSCH J. G., STRAUSS B. STUDIES ON HEAT-LABILE OPSONIN IN RABBIT SERUM. J Immunol. 1964 Jan;92:145–154. [PubMed] [Google Scholar]
  10. Jasin H. E. Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation. J Immunol. 1972 Jul;109(1):26–31. [PubMed] [Google Scholar]
  11. Johnson F. R., Agnello V., Williams R. C., Jr Opsonic activity in human serum deficient in C2. J Immunol. 1972 Jul;109(1):141–145. [PubMed] [Google Scholar]
  12. Johnston R. B., Jr, Klemperer M. R., Alper C. A., Rosen F. S. The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors. J Exp Med. 1969 Jun 1;129(6):1275–1290. doi: 10.1084/jem.129.6.1275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. MELLY M. A., THOMISON J. B., ROGERS D. E. Fate of staphylococci within human leukocytes. J Exp Med. 1960 Dec 1;112:1121–1130. doi: 10.1084/jem.112.6.1121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. McLean R. H., Michael A. F. Properdin anc C3 proactivator: alternate pathway components in human glomerulonephritis. J Clin Invest. 1973 Mar;52(3):634–644. doi: 10.1172/JCI107225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Miyakawa Y., Sekine T., Shimada K., Nishioka K. High efficiency of SAC1gp4gp2gp conversion to S with EDTA-treated rat serum. J Immunol. 1969 Aug;103(2):374–377. [PubMed] [Google Scholar]
  16. Morrison D. C., Kline L. F. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol. 1977 Jan;118(1):362–368. [PubMed] [Google Scholar]
  17. NELSON R. A., Jr, LEBRUN J. The requirement for antibody and complement for in vitro phagocytosis of starch granules. J Hyg (Lond) 1956 Mar;54(1):8–19. doi: 10.1017/s0022172400044259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nelson R. A., Jr, Jensen J., Gigli I., Tamura N. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum. Immunochemistry. 1966 Mar;3(2):111–135. doi: 10.1016/0019-2791(66)90292-8. [DOI] [PubMed] [Google Scholar]
  19. Opferkuch W., Rapp H. J., Colten H. R., Borsos T. Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. 3. The hemolytic efficiency of human and guinea pig C2 and C4. J Immunol. 1971 Apr;106(4):927–931. [PubMed] [Google Scholar]
  20. Osterland C. K., Espinoza L., Parker L. P., Schur P. H. Inherited C2 deficiency and systemic lupus erythematosus: studies on a family. Ann Intern Med. 1975 Mar;82(3):323–328. doi: 10.7326/0003-4819-82-3-323. [DOI] [PubMed] [Google Scholar]
  21. Polley M. J., Müller-Eberhard H. J. The second component of human complement: its isolation, fragmentation by C'1 esterase, and incorporation into C'3 convertase. J Exp Med. 1968 Sep 1;128(3):533–551. doi: 10.1084/jem.128.3.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Repine J. E., White J. G., Clawson C. C., Holmes B. M. Effects of phorbol myristate acetate on the metabolism and ultrastructure of neutrophils in chronic granulomatous disease. J Clin Invest. 1974 Jul;54(1):83–90. doi: 10.1172/JCI107752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. SMITH M. R., WOOD W. B., Jr Surface phagocytosis; further evidence of its destructive action upon fully encapsulated pneumococci in the absence of type-specific antibody. J Exp Med. 1958 Jan 1;107(1):1–12. doi: 10.1084/jem.107.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. STIFFEL C., BIOZZI G., MOUTON D., BOUTHILLIER Y., DECREUSEFOND C. STUDIES ON PHAGOCYTOSIS OF BACTERIA BY THE RETICULOENDOTHELIAL SYSTEM IN A STRAIN OF MICE LACKING HEMOLYTIC COMPLEMENT. J Immunol. 1964 Aug;93:246–249. [PubMed] [Google Scholar]
  25. Smith M. R., Wood W. B., Jr Heat labile opsonins to pneumococcus. I. Participation of complement. J Exp Med. 1969 Dec 1;130(6):1209–1227. doi: 10.1084/jem.130.6.1209. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Stossel T. P., Alper C. A., Rosen F. S. Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide. J Exp Med. 1973 Mar 1;137(3):690–705. doi: 10.1084/jem.137.3.690. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Sussman M., Jones J. H., Almeida J. D., Lachmann P. J. Deficiency of the second component of complement associated with anaphylactoid purpura and presence of mycoplasma in the serum. Clin Exp Immunol. 1973 Aug;14(4):531–539. [PMC free article] [PubMed] [Google Scholar]
  28. Wheat L. J., Humphreys D. W., White A. Opsonization of staphylococci by normal human sera: the role of antibody and heat-labile factors. J Lab Clin Med. 1974 Jan;83(1):73–78. [PubMed] [Google Scholar]
  29. Wood W. B., Jr, Smith M. R. Intercellular Surface Phagocytosis. Science. 1947 Jul 25;106(2743):86–87. doi: 10.1126/science.106.2743.86. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES